Tag archive for ‘Mallinckrodt’
Cadence: A Post Mortem on a Successful Investment and What to Do with the Proceeds (CADX, $14.00)
Mallinckrodt (MNK) announced that one of its subsidiaries will start a tender offer to acquire all of the outstanding shares of Cadence for $14.00 per share. This represents a 32% premium to the trailing 30-trading-day volume weighted average price of $10.62 per share for Cadence Pharmaceuticals, Inc. The transaction is expected to close in mid […]